Satellos Bioscience MSLE
NASDAQ MSLE
$6.75 -0.45 (-6.25%)
At close: Nov 11, 2026 · 4:00 PM EST

Satellos Bioscience (MSLE) Income towards Parent Company (2025 - 2026)

Updated

Satellos Bioscience (MSLE) reported Income towards Parent Company of -$11.72 million for the quarter ended Jun 30, 2026, compared with -$5.61 million a year earlier.

Analysis

Satellos Bioscience (MSLE) Income towards Parent Company (2025 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Satellos Bioscience's Income towards Parent Company came in at -$51.95 million; for the year ended Dec 31, 2025, it came in at -$24.87 million.

  • By year, Income towards Parent Company came in at -$20.63 million in the year ended Dec 31, 2024.
  • Five-year quarterly Income towards Parent Company spans a low of -$24.87 million in the quarter ended Dec 31, 2025 and a high of $6.14 million in the quarter ended Mar 31, 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Satellos Bioscience 109.60 Mn -98.54 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -11.72 Mn
Mar 31, 2026 -9.77 Mn
Jun 30, 2025 -5.61 Mn
Mar 31, 2025 -6.14 Mn
API Access

Satellos Bioscience Income towards Parent Company API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=MSLE&period=max&api_key=YOUR_API_KEY